drugset / Trial / NCT06373094
A Single Dose Escalation Study of HHT201 in Healthy Subjects
Non-randomizedSequentialOpen-labelTreatment
Summary
The objective of this study is to evaluate the safety and pharmacokinetic profiles of HHT201 in healthy subjects.
Timeline
- Start
- 2024-06-01
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 34 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 68 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 136 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 204 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 306 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 408 mg | Intramuscular |